Cargando…

Type 1 Brugada phenotype induced by cardiac iron overload after blood transfusion

Detalles Bibliográficos
Autores principales:	Sun, Xue-Rong, Liu, Tong, Liu, Xing-Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156983/ https://www.ncbi.nlm.nih.gov/pubmed/32322493 http://dx.doi.org/10.1016/j.hrcr.2019.12.011

Ejemplares similares

Iron overload status in patients with non-transfusion-dependent thalassemia in China
por: Huang, Yumei, et al.
Publicado: (2022)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

Korean Guideline for Iron Chelation Therapy in Transfusion-Induced Iron Overload
por: Jang, Jun Ho, et al.
Publicado: (2013)

Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion
por: Cappellini, Maria Domenica
Publicado: (2007)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemia
por: Sayed, Samira Zein, et al.
Publicado: (2023)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions
por: Chalmers, Anna W, et al.
Publicado: (2016)

Iron overload across the spectrum of non‐transfusion‐dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
por: Porter, John B., et al.
Publicado: (2016)

Clinical outcomes of transfusion-associated iron overload in patients with refractory chronic anemia
por: Gao, Chong, et al.
Publicado: (2014)

Iron overload during the treatment of acute leukemia: pretransplant transfusion experience
por: Yokus, Osman, et al.
Publicado: (2021)

Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia
por: Olufemi, Akodu Samuel, et al.
Publicado: (2021)

Pulmonary function in patients with transfusion-dependent thalassemia and its associations with iron overload
por: Chan, Kate C., et al.
Publicado: (2023)

Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Preoperative Iron Deficiency Is Associated With Increased Blood Transfusion in Infants Undergoing Cardiac Surgery
por: Gao, Peng, et al.
Publicado: (2022)

Transfusion associated circulatory overload
por: Agnihotri, Naveen, et al.
Publicado: (2014)

Brugada syndrome—Malignant phenotype associated with acute cardiac inflammation?
por: Li, Anthony, et al.
Publicado: (2017)

A European survey on the detection and management of iron overload in transfusion-dependent patients with MDS
por: Giagounidis, Aristoteles, et al.
Publicado: (2011)

Oxidative Stress (Malondialdehyde) in Adults Beta-Thalassemia Major and Intermedia: Comparison Between Before and After Blood Transfusion and Its Correlation with Iron Overload
por: Atmakusuma, Tubagus Djumhana, et al.
Publicado: (2021)

Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
por: Karami, Hossein, et al.
Publicado: (2017)

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
por: Origa, Raffaella, et al.
Publicado: (2022)

Effects of digoxin on cardiac iron content in rat model of iron overload
por: Nasri, Hamid Reza, et al.
Publicado: (2016)

Comment on: “Transfusion associated circulatory overload”
por: Ho, James K. H., et al.
Publicado: (2014)

An Iron Refractory Phenotype in Obese Adipose Tissue Macrophages Leads to Adipocyte Iron Overload
por: Ameka, Magdalene K., et al.
Publicado: (2022)

Secondary hemochromatosis as a result of acute transfusion-induced iron overload in a burn patient
por: Amatto, Michael, et al.
Publicado: (2016)

Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq
por: Ahmed, Rana Adnan, et al.
Publicado: (2022)

Transfusion burden in early childhood plays an important role in iron overload in Diamond‐Blackfan anaemia
por: de Wilde, Jonathan R. A., et al.
Publicado: (2022)

Role of Flavonoids in the Treatment of Iron Overload
por: Wang, Xiaomin, et al.
Publicado: (2021)

Blood transfusion and iron overload in patients with Sickle Cell Disease (SCD): Personal experience and a short update of diabetes mellitus occurrence
por: Soliman, Ashraf T, et al.
Publicado: (2022)

P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED
por: van Beers, Eduard, et al.
Publicado: (2023)

Iron overload disorders
por: Hsu, Christine C., et al.
Publicado: (2022)

Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy
por: Oudit, Gavin Y., et al.
Publicado: (2006)

Cardiac iron overload promotes cardiac injury in patients with severe COVID-19
por: Baier, Maria J., et al.
Publicado: (2021)

Iron Chelators in Treatment of Iron Overload
por: Entezari, Sarina, et al.
Publicado: (2022)

Iron-Storage Protein Ferritin Is Upregulated in Endometriosis and Iron Overload Contributes to a Migratory Phenotype
por: Woo, Jeong-Hwa, et al.
Publicado: (2020)

The Correlation Between Iron Overload and Endocrine Function in Adult Transfusion-Dependent Beta-Thalassemia Patients with Growth Retardation
por: Atmakusuma, Tubagus Djumhana, et al.
Publicado: (2021)

Optimized serum ferritin prediction of iron overload in transfusion-dependent thalassemia: likelihood ratio and age-adjustment approach
por: Kurban, Lutfi Ali, et al.
Publicado: (2023)

Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice
por: Mattè, Alessandro, et al.
Publicado: (2023)

Longitudinal assessment of structural phenotype in Brugada syndrome using cardiac magnetic resonance imaging
por: Isbister, Julia C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_da1e43b6td2akh7v2u5omr1dd8